As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of diagnostic biomarkers of ovarian cancer, which are listed below:

1. “Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1”
by Yvonne Grobben, Judith E. den Ouden, Cristina Aguado, Anne M. van Altena, Aletta D. Kraneveld and Guido J. R. Zaman
Cancers 2023, 15(3), 893; https://doi.org/10.3390/cancers15030893
Available online: https://doi.org/10.3390/cancers15030893

2. “Identification and Characterization of Aptamers Targeting Ovarian Cancer Biomarker Human Epididymis Protein 4 for the Application in Urine”
by Antonija Hanžek, Frédéric Ducongé, Christian Siatka and Anne-Cécile E. Duc
Cancers 2023, 15(2), 452; https://doi.org/10.3390/cancers15020452
Available online: https://doi.org/10.3390/cancers15020452

3. “Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets”
by Julia Oto, Quang-Khoi Le, Sebastian D. Schäfer, Ludwig Kiese, Josep Marí-Alexandre, Juan Gilabert-Estellés, Pilar Medina and Martin Götte
Cancers 2023, 15(12), 3125; https://doi.org/10.3390/cancers15123125
Available online: https://doi.org/10.3390/cancers15123125

4. “Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers”
by Vikneswary Ravi Kumar, Nirmala Chandralega Kampa, Nor Haslinda Abd Aziz, Chew Kah Teik, Mohamad Nasir Shafiee and P. Susthitha Menon
Cancers 2023, 15(23), 5607; https://doi.org/10.3390/cancers15235607
Available online: https://doi.org/10.3390/cancers15235607

5. “Glucose-Regulated Protein 78 Is a Potential Serum and Imaging Marker for Early Detection of Ovarian Cancer”
by Elizabeth A. Paris, Janice M. Bahr, Jacques S. Abramowicz, Sanjib Basu and Animesh Barua
Cancers 2023, 15(4), 1140; https://doi.org/10.3390/cancers15041140
Available online: https://doi.org/10.3390/cancers15041140

6. “Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women”
by Chloe E. Barr, Kelechi Njoku, Gemma L. Owens and Emma J. Crosbie
Cancers 2023, 15(4), 1256; https://doi.org/10.3390/cancers15041256
Available online: https://doi.org/10.3390/cancers15041256

7. “A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer”
by Andrew N. Stephens, Simon J. Hobbs, Sung-Woon Kang, Maree Bilandzic, Adam Rainczuk, Martin K. Oehler, Tom W. Jobling, Magdalena Plebanski and Richard Allman
Cancers 2023, 15(21), 5267; https://doi.org/10.3390/cancers15215267
Available online: https://doi.org/10.3390/cancers15215267

8. “The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition”
by Graziana Scavone, Silvia Ottonello, Eva Blondeaux, Luca Arecco, Paola Scaruffi, Sara Stigliani, Barbara Cardinali, Roberto Bore, Michele Paudice, Valerio G. Vellone et al.
Cancers 2023, 15(20), 4923; https://doi.org/10.3390/cancers15204923
Available online: https://doi.org/10.3390/cancers15204923

9. “PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer”
by Henriett Butz, Petra Nagy, János Papp, Anikó Bozsik, Vince Kornél Grolmusz, Tímea Pócza, Edit Oláh and Attila Patócs
Cancers 2023, 15(17), 4350; https://doi.org/10.3390/cancers15174350
Available online: https://doi.org/10.3390/cancers15174350

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office